Telangana Minister K T Rama Rao inaugrates Ferring Pharma Genome Valley facility

Hyderabad: Telangana Minister for Information Technology and Industries K T Rama Rao inaugurated the Ferring Pharmaceuticals facility at Genome Valley here on Monday established with a total investment of about 30 Million Euros.

The facility will employ around 110 people. Headquartered in Saint-Prex, Switzerland, the pharmaceutical company specializes in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth.

Speaking on the occasion, Rama Rao, while congratulating Ferring Pharma said, "We are extremely happy to welcome Ferring Pharmaceuticals, which is a global biopharmaceutical group, having about 12 R&D Centers and 13 Manufacturing Sites across the globe. This facility is truly state-of-the-art with unique capabilities in formulation development, packaging development and analytical development, the Minister said the company will focus on developing and manufacturing urology products".

Francois Hosotte, Vice President Strategic Projects & Engineering, Ferring Pharmaceuticals said, in pursuit of our mission to become a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology we have invested 18 percent of our 2B euros Revenue in R&D.

Ferring harnesses its world-class competencies in science and business with other innovative technologies to create solutions for patients and doctors, he said this campus is a living embodiment of our mission.

This campus is bringing together Development and Production activities in two separate buildings, Hosotte added.

Anindya Ghosh, Managing Director, Ferring Laboratories Private Limited (Ferring Pharmaceuticals) said, "this Site in Hyderabad is an integrated facility with R&D and Manufacturing capability. The R&D capability includes Formulation Development, Packaging Development and Analytical Development. The Manufacturing facility is mainly designed for Oral Solid Dosage Form.